Stryker completes acquisition of Mobius Imaging and Cardan Robotics
October 21 2019 - 8:05AM
Stryker (NYSE: SYK) announced today it has completed the
acquisition of Mobius Imaging, LLC, a leader in point-of-care
imaging technology, and its sister company, GYS Tech, LLC (DBA
Cardan Robotics).
“Mobius Imaging and Cardan Robotics bring expertise in advanced
imaging and robotics, as well as a robust product pipeline, that
will provide Stryker the opportunity to increase its presence in
Orthopaedics, Spine and Neurotechnology,” said Spencer Stiles,
Stryker’s Group President, Orthopaedics and Spine. “With this
acquisition, we are positioned to make healthcare better by
providing more complete procedural solutions, including sales,
service, and support. We remain committed to our surgeons and
helping them achieve the best possible outcomes for their
patients.”
Forward-looking statements
This press release contains information that includes or is
based on forward-looking statements within the meaning of the
federal securities law that are subject to various risks and
uncertainties that could cause our actual results to differ
materially from those expressed or implied in such statements. Such
factors include, but are not limited to: the failure to satisfy any
of the closing conditions, including the receipt of any required
regulatory clearances; delays in consummating the acquisition
of Mobius Imaging and GYS Tech; unexpected charges or expenses
in connection with the acquisition of Mobius Imaging and GYS
Tech; weakening of economic conditions that could adversely affect
the level of demand for our products; pricing pressures generally,
including cost-containment measures that could adversely affect the
price of or demand for our products; changes in foreign exchange
markets; legislative and regulatory actions; unanticipated issues
arising in connection with clinical studies and otherwise that
affect U.S. Food and Drug Administration approval of new
products, including Mobius Imaging products; potential
supply disruptions; changes in reimbursement levels from
third-party payors; a significant increase in product liability
claims; the ultimate total cost with respect to recall-related
matters; the impact of investigative and legal proceedings and
compliance risks; resolution of tax audits; the impact of the
federal legislation to reform the United States healthcare
system; costs to comply with medical device regulations; changes in
financial markets; changes in the competitive environment; our
ability to integrate acquisitions, including the acquisition
of Mobius Imaging and GYS Tech; and our ability to realize
anticipated cost savings. Additional information concerning these
and other factors is contained in our filings with the U.S.
Securities and Exchange Commission, including our Annual Report on
Form 10-K and Quarterly Reports on Form 10-Q.
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in Orthopaedics, Medical and Surgical, and Neurotechnology
and Spine that help improve patient and hospital outcomes. More
information is available at www.stryker.com.
Contacts
For investor inquiries please contact:Katherine
Owen, Vice President, Strategy & Investor Relations at
269-385-2600 or katherine.owen@stryker.com
For media inquiries please contact:Yin Becker,
Vice President, Communications, Public Affairs and Corporate
Marketing at 269-385-2600 or yin.becker@stryker.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Apr 2023 to Apr 2024